10000
190
6
3
1
Cat. No. | Product Name | ||
---|---|---|---|
L8500 | HIF-1化合物库 | 1352 compounds | |
xnu |
|||
DC1160 | 特权片段注释化合物库-Toll-like and Il-1 receptors | 3536 compounds | |
L2800 | 5-羟色胺分子库 | 275 compounds | |
xnu |
|||
DP9100 | CB1-2化合物库 | ||
DP5580 | Ephrin-4B靶向化合物库 | ||
L5100 | 含氟化合物库 | 583 compounds | |
xnu |
|||
L9610 | 环肽库 | 58 compounds | |
xnu |
|||
L8720 | 细胞焦亡化合物库 | 1077 compounds | |
xnu |
|||
L7600 | 趋化因子抑制剂库 | 59 compounds | |
xnu |
|||
L2550 | 谷氨酰胺代谢化合物库 | 580 compounds | |
xnu |
|||
L2400 | 内分泌激素分子库 | 813 compounds | |
xnu |
|||
L1600 | 激酶抑制剂库 | 2230 compounds | |
xnu |
|||
L9600 | 多肽分子库 | 533 compounds | |
xnu |
|||
L9410 | 共价抑制剂库 | 941 compounds | |
xnu |
|||
L1100 | 蛋白酶抑制剂库 | 344 compounds | |
xnu |
|||
L2570 | 人代谢物化合物库 | 4532 compounds | |
xnu |
|||
L3800 | NF-κB 通路分子库 | 560 compounds | |
xnu |
|||
L2130 | 抗癌细胞代谢库 | 1280 compounds | |
xnu |
|||
L3300 | 组胺&褪黑色素化合物库 | 155 compounds | |
xnu |
|||
L5600 | Mini骨架库 | 5033 compounds | |
多样性好,从一百多万个小分子中挑选而出,xnu |
|||
L2500 | 人内源代谢化合物库 | 1400 compounds | |
xnu |
|||
L4300 | Wnt/Hedgehog/Notch 通路化合物库 | 240 compounds | |
xnu |
|||
L5900 | 血脑屏障通透化合物库 | 516 compounds | |
xnu |
|||
L6160 | Ro5类药天然产物库 | 2743 compounds | |
天然产物是先导化合物及候选药物的重要来源,其骨架结构复杂,官能团丰富,结构独特,多具有手性。这些自然形成的优势,为天然产物向药物的转化提供了更加多样的选择, 也是天然产物在药物开发与研究中发挥着重要作用的原因。
Target |
|||
L8400 | 血液病分子库 | 524 compounds | |
xnu |
|||
L3510 | 甲基化化合物库 | 131 compounds | |
xnu |
|||
L2192 | 抗胰腺癌化合物库 | 2267 compounds | |
xnu |
|||
DO1200 | 药物靶点库 | 54000 compounds | |
数量多,含 |
|||
L2180 | 抗肿瘤库Plus | 1468 compounds | |
xnu |
|||
L8300 | 染色质修饰分子库 | 256 compounds | |
xnu |
|||
L3600 | 细胞因子抑制剂库 | 613 compounds | |
xnu |
|||
L9420 | 外泌体相关化合物库 | 54 compounds | |
xnu |
|||
L6600 | 胃肠炎天然产物库 | 223 compounds | |
xnu |
|||
L6030 | 天然产物衍生物虚筛化合物库 | 135000 compounds | |
|
|||
L6120 | 黄酮类天然产物库 | 477 compounds | |
xnu |
|||
L1580 | GPCR库Plus | 338 compounds | |
xnu |
|||
NY1000 | 天然产物衍生物库 | 4000 compounds | |
|
|||
L6700 | 抗癌天然产物库 | 1471 compounds | |
xnu |
|||
DF4500 | 多样性核心库Part1 | 50000 compounds | |
绝大部分分子量< |
|||
L5610 | Golden骨架库 | 10000 compounds | |
多样性好,从 |
|||
L9840 | 抗阿尔茨海默症化合物库 | 1040 compounds | |
xnu |
|||
L7800 | 高溶解性片段库 | 2731 compounds | |
xnu |
|||
L2191 | 抗乳腺癌化合物库 | 1965 compounds | |
xnu |
|||
L4150 | 新颖已知活性精选库 | 990 compounds | |
xnu |
|||
DO2200 | 共价抑制剂库CD | 12000 compounds | |
数量多:超过 |
|||
L9830 | 抗帕金森病化合物库 | 908 compounds | |
xnu |
|||
L1710 | 抗COVID-19化合物库 | 1160 compounds | |
xnu |
|||
L9500 | 表型筛选靶点鉴定库 | 1832 compounds | |
xnu |
|||
L1120 | AMPK靶向分子库 | 64 compounds | |
xnu |
|||
L6210 | 藏药化合物库 | 754 compounds | |
xnu |
|||
L7300 | 钾通道分子库 | 160 compounds | |
xnu |
|||
L6010 | 天然产物库 | 3720 compounds | |
xnu |
|||
L2600 | 神经信号分子库 | 2011 compounds | |
xnu |
|||
L2610 | 神经递质受体化合物库 | 1513 compounds | |
xnu |
|||
L5700 | 精选片段库 | 246 compounds | |
xnu |
|||
L4400 | 抗生素库 | 708 compounds | |
xnu |
|||
L8100 | 细胞周期化合物库 | 695 compounds | |
xnu |
|||
L3700 | JAK-STAT 化合物库 | 256 compounds | |
xnu |
|||
L3980 | DNA损伤/修复库Plus | 667 compounds | |
xnu |
|||
L8800 | 药物片段库 | 1158 compounds | |
xnu |
|||
L9000 | 细胞凋亡化合物库 | 1796 compounds | |
xnu |
|||
L1300 | PI3K/Akt/mTOR 化合物库 | 425 compounds | |
xnu |
|||
L1610 | FDA 上市激酶抑制剂库 | 280 compounds | |
Target |
|||
L2520 | 糖代谢化合物库 | 708 compounds | |
xnu |
|||
L2540 | 肠道微生物代谢化合物库 | 352 compounds | |
xnu |
|||
L9700 | 内质网应激化合物库 | 193 compounds | |
xnu |
|||
L8700 | 铁死亡化合物库 | 800 compounds | |
xnu |
|||
VM1400 | 多样性核心库Part2 | 25920 compounds | |
分子量< |
|||
L7100 | 抗肥胖化合物库 | 1359 compounds | |
xnu |
|||
L7110 | 抗高血压化合物库 | 719 compounds | |
xnu |
|||
L7500 | 凝血与抗凝化合物库 | 154 compounds | |
xnu |
|||
DC1140 | 特权片段注释化合物库-Ligand-gated | 9028 compounds | |
L2000 | 抑制剂库 | 7618 compounds | |
xnu |
|||
L9230 | ReFRAME 化合物库 | 3274 compounds | |
xnu |
|||
DC1180 | 特权片段注释化合物库-Lyases | 19530 compounds | |
L4900 | 心血管毒性化合物库 | 127 compounds | |
xnu |
|||
DP9200 | DGK抑制剂库 | 12000 compounds | |
包含 |
|||
L5300 | 线粒体靶向库 | 447 compounds | |
xnu |
|||
L9210 | 儿童药物库 | 1015 compounds | |
xnu |
|||
L6020 | 天然产物单体化合物库 | 19377 compounds | |
xnu |
|||
LF1000 | 预制多样性库 | 50000 compounds | |
For your convenience, there are Diversity Sets of |
|||
L1380 | 转录因子库 | 704 compounds | |
xnu |
|||
DC1150 | 特权片段注释化合物库-GPCR Family B | 9320 compounds | |
DC1170 | 特权片段注释化合物库-Oxidoreductases | 8812 compounds | |
L9411 | 半胱氨酸共价化合物库 | 72 compounds | |
半胱氨酸共价库包含xnu |
|||
L4660 | 神经疾病库Plus | 1246 compounds | |
xnu |
|||
L3500 | 组蛋白修饰化合物库 | 362 compounds | |
xnu |
|||
DC1190 | 特权片段注释化合物库-Sigma Opioid receptors | 8724 compounds | |
L3900 | DNA 损伤和修复分子库 | 937 compounds | |
xnu |
|||
L2160 | 抗癌活性化合物库 | 2439 compounds | |
xnu |
|||
L2110 | 抗癌上市药物库 | 1806 compounds | |
xnu |
|||
L3200 | 自噬库 | 1248 compounds | |
xnu |
|||
L7820 | 高溶解性微型片段化合物库 | 1082 compounds | |
高溶解性微型片段化合物库由 xnu |
|||
L7200 | 钙通道分子库 | 143 compounds | |
xnu |
|||
L5400 | 抗心血管疾病化合物库 | 1428 compounds | |
xnu |
|||
DC1040 | 特权片段注释化合物库-Transferases | 23001 compounds | |
L9400 | PPI抑制剂库 | 260 compounds | |
xnu |
|||
L7000 | 活性脂质化合物库 | 385 compounds | |
xnu |
|||
L1200 | 表观遗传库 | 960 compounds | |
xnu |
|||
DC1030 | 特权片段注释化合物库-Epigenetics | 9196 compounds | |
L1000 | 上市药物库 | 2863 compounds | |
xnu |
|||
L2200 | 酪氨酸激酶分子库 | 746 compounds | |
xnu |
|||
L7900 | 成骨分子库 | 320 compounds | |
xnu |
|||
L8600 | 泛素化化合物库 | 214 compounds | |
xnu |
|||
L6620 | 抗寄生虫天然产物库 | 233 compounds | |
xnu |
|||
L2700 | 肾上腺素能受体化合物库 | 219 compounds | |
xnu |
|||
L1110 | 微管靶向化合物库 | 80 compounds | |
xnu |
|||
L9810 | 抗纤维化化合物库 | 1180 compounds | |
xnu |
|||
L2120 | 抗癌临床化合物库 | 2359 compounds | |
xnu |
|||
L6500 | 微生物天然产物库 | 193 compounds | |
xnu |
|||
L2151 | 化疗药物库 | 51 compounds | |
xnu |
|||
L7860 | Mini片段亲电杂环化合物库 | 369 compounds | |
高溶解度共价杂环片段库中的 xnu |
|||
L6400 | 海洋天然产物库 | 94 compounds | |
xnu |
|||
L6610 | 抗感染天然产物库 | 1070 compounds | |
xnu |
|||
L6150 | 天然产物共价化合物库 | 596 compounds | |
提供产品的生物学信息和药物学信息,为筛选提供理论方向和研究基础; | |||
DC1100 | 特权片段注释化合物库-GPCR Frizzled family | 3434 compounds | |
L7810 | 高溶解性多官能团片段化合物库 | 1159 compounds | |
高溶解性多官能团片段库包含xnu |
|||
DC1200 | 特权片段注释化合物库-Isomerases | 1206 compounds | |
L5500 | 毒性化合物库 | 277 compounds | |
xnu |
|||
L6720 | 抗COVID-19中药单体库 | 1162 compounds | |
根据抗新冠肺炎疫情过程中应用于临床治疗的中药方剂,收集了xnu |
|||
L1310 | 细胞骨架化合物库 | 590 compounds | |
xnu |
|||
L1800 | 抗感染化合物库 | 2977 compounds | |
xnu |
|||
L8000 | 干细胞分化化合物库 | 1213 compounds | |
xnu |
|||
L6710 | 中药抗炎分子库 | 1040 compounds | |
xnu |
|||
L2510 | 脂代谢化合物库 | 496 compounds | |
xnu |
|||
L9820 | β-内酰胺类化合物库 | 105 compounds | |
xnu |
|||
L4500 | 抗真菌库 | 253 compounds | |
xnu |
|||
L3100 | 造血毒性小分子库 | 104 compounds | |
xnu |
|||
L7850 | 高溶解性3D结构多样性片段化合物库 | 1081 compounds | |
高溶解性 |
|||
L2300 | 离子通道库 | 946 compounds | |
xnu |
|||
L4600 | 植物来源化合物库 | 2720 compounds | |
xnu |
|||
DC1050 | 特权片段注释化合物库-Voltage-gated | 17952 compounds | |
L2560 | 代谢化合物库 | 2350 compounds | |
xnu |
|||
L6300 | 药食同源库 | 1088 compounds | |
xnu |
|||
DC1110 | 特权片段注释化合物库-Proteases | 22863 compounds | |
L6130 | 萜类天然产物库 | 349 compounds | |
xnu |
|||
L6220 | 蒙药化合物库 | 960 compounds | |
xnu |
|||
DC1010 | 特权片段注释化合物库-GPCR Family A | 24763 compounds | |
L8200 | 抗衰老化合物库 | 3324 compounds | |
xnu |
|||
L2530 | 小鼠代谢化合物库 | 224 compounds | |
xnu |
|||
L7840 | 高溶解性卤化片段化合物库 | 796 compounds | |
高溶解性卤化片段库包含xnu |
|||
L9100 | 磷酸酶抑制剂化合物库 | 80 compounds | |
xnu |
|||
DC1000 | 特权片段注释化合物库 | 190000 compounds | |
The database contains |
|||
L4100 | TGF-β/Smad靶点化合物库 | 180 compounds | |
xnu |
|||
L6100 | 天然多酚类化合物库 | 640 compounds | |
xnu |
|||
L7830 | 高溶解性片段药效团化合物库 | 985 compounds | |
高溶解性片段药效团库包含xnu |
|||
DP1300 | h-TERT靶向化合物库 | ||
L6810 | 中药单体化合物库 | 2688 compounds | |
xnu |
|||
DC1130 | 特权片段注释化合物库-Phosphodiesterases | 13154 compounds | |
DC1060 | 特权片段注释化合物库-Kinases | 18350 compounds | |
L1720 | 核苷类化合物库 | 337 compounds | |
xnu |
|||
L2900 | 氧化还原化合物库 | 1279 compounds | |
xnu |
|||
L9200 | 药物功能重定位化合物库 | 4240 compounds | |
xnu |
|||
DC1220 | 特权片段注释化合物库-Aminoacyltransferases | 3008 compounds | |
L6110 | 生物碱类天然产物库 | 468 compounds | |
xnu |
|||
DC1210 | 特权片段注释化合物库-Phosphatases | 15354 compounds | |
L9300 | 大环化合物库 | 155 compounds | |
xnu |
|||
DC1090 | 特权片段注释化合物库-Ligases | 11828 compounds | |
L7700 | 神经再生化合物库 | 529 compounds | |
xnu |
|||
L5510 | 肝脏毒性化合物库 | 1040 compounds | |
xnu |
|||
L2100 | 抗癌化合物库 | 6854 compounds | |
xnu |
|||
DQ3000 | Factor XIa化合物库 | 6500 compounds | |
L6200 | 瑶药化合物库 | 225 compounds | |
xnu |
|||
DC1080 | 特权片段注释化合物库-GPCR Taste family | 2675 compounds | |
DC1120 | 特权片段注释化合物库-Thrombopoietin receptors | 4908 compounds | |
L5800 | 药物代谢杂质库 | 200 compounds | |
xnu |
|||
L4010 | 已知活性化合物库 | 20980 compounds | |
xnu |
|||
L6900 | 稀有天然产物库 | 284 compounds | |
xnu |
|||
L4020 | NO PAINS 化合物库 | 9555 compounds | |
Target |
|||
L4800 | 血管生成库 | 1370 compounds | |
xnu |
|||
L1700 | 抗病毒库 | 800 compounds | |
xnu |
|||
L1510 | 核受体化合物库 | 420 compounds | |
xnu |
|||
DC1230 | 特权片段注释化合物库-Beta amyloid A4 protein | 4617 compounds | |
L6140 | 糖类及苷类化合物库 | 364 compounds | |
xnu |
|||
L3400 | 临床期小分子药物库 | 3142 compounds | |
xnu |
|||
L8110 | 细胞重编程化合物库 | 1840 compounds | |
xnu |
|||
L2140 | 癌细胞分化化合物库 | 413 compounds | |
xnu |
|||
L5200 | 抗代谢疾病化合物库 | 1558 compounds | |
xnu |
|||
L2152 | 靶向治疗药物库 | 121 compounds | |
xnu |
|||
L1400 | MAPK 抑制剂库 | 367 compounds | |
xnu |
|||
L6800 | 中国药典收录天然产物库 | 2070 compounds | |
xnu |
|||
DC1070 | 特权片段注释化合物库-GPCR Family C | 5071 compounds | |
L2190 | 抗肺癌化合物库 | 1735 compounds | |
xnu |
|||
L1900 | 抗糖尿病库 | 690 compounds | |
xnu |
|||
L2910 | 抗氧化化合物库 | 1040 compounds | |
氧化应激(Oxidative Stress,OS)是指体内氧化与抗氧化作用失衡的一种状态。氧化应激导致活性氧(ROS)大量积累,氧化程度超出抗氧化物的清除能力,从而引起氧化损伤,氧化应激损伤是许多疾病发生的基础,不同程度的氧化应激造成的细胞效应与心脑血管疾病、神经退行性病变、炎症和肿瘤密切相关。抗氧化剂是一类能够对抗氧化应激,降低氧化损伤的一类化合物。
Target |
|||
L7870 | 可溶性羧酸片段化合物库 | 1807 compounds | |
可溶性羧酸片段库包含xnu |
|||
L7400 | 钠通道分子库 | 128 compounds | |
xnu |
|||
L6000 | 高通量筛选天然产物库 | 4320 compounds | |
xnu |
|||
L4700 | 免疫/炎症分子化合物库 | 3483 compounds | |
xnu |
|||
L2521 | 糖酵解化合物库 | 560 compounds | |
xnu |
Cat. No. | Product Name | Form | Specificity Of Inhibition |
---|---|---|---|
C0004 |
Phosphatase Inhibitor Cocktail III (2 Tubes, 100x)
磷酸酶抑制剂 Cocktail III |
Each Tube has different specificity of inhibition | |
C0005 |
Cell Counting Kit-8 (CCK-8)
Cell Counting Kit-8 (CCK-8) |
||
C0003 |
Phosphatase Inhibitor Cocktail II (100× DMSO)
磷酸酶抑制剂 Cocktail II |
Alkaline phosphatases, Ser/Thr phosphatases, Acid and PP<e<em>m</em>><e<em>m</em>><em><em>1</em></em></e<em>m</em>></e<em>m</em>> and PP<e<em>m</em>><em>2</em></e<em>m</em>>A | |
C0008 |
SYBR Green qPCR Master Mix (Low ROX)
SYBR Green qPCR Master Mix (Low ROX) |
||
C0007 |
SYBR Green qPCR Master Mix (High ROX)
SYBR Green qPCR Master Mix (High ROX) |
||
C0006 |
SYBR Green qPCR Master Mix (No ROX)
SYBR Green qPCR Master Mix (No ROX) |
Cat. No. | Product Name | ||
---|---|---|---|
EC2000 | 全自动封板仪 | ||
Target |
Cat. No. | Product Name | ||
---|---|---|---|
EC3000 | TargetMol® 24 道磁力架 | ||
强力钕磁铁部件,吸附效率高,可兼容所有磁珠。助力核酸分离、蛋白纯化、细胞分选!可同时分离 |
|||
EC3001 | TargetMol® 16 道磁力架 | ||
强力钕磁铁部件,吸附效率高,可兼容所有磁珠。助力核酸分离、蛋白纯化、细胞分选!可同时分离 |
|||
EC4000 | TargetMol® 高通量开盖器 | ||
Target |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T9828 | N-[1-(Aminocarbonyl)-4-[(2-chloro-1-iminoethyl)amino]butyl]benzamide | PAD | Chromatin/Epigenetic |
N-[1-(Aminocarbonyl)-4-[(2-chloro-1-iminoethyl)amino]butyl]benzamide 是Cl-amidine (S 构型)的消旋形式。Cl-amidine 口服有效的 PAD 抑制剂。 | |||
T9998 | 4H-1,2,4-Triazole, 3-(phenoxymethyl)-4-phenyl-5-[(phenylmethyl)thio]- | Sirtuin | Chromatin/Epigenetic; DNA Damage/DNA Repair |
4H-1,2,4-Triazole, 3-(phenoxymethyl)-4-phenyl-5-[(phenylmethyl)thio]- 是一种具有抗肿瘤活性的 SIRT2 抑制剂。 | |||
T60186 | (S)-4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-2-(pyrimidin-5-yl)-1,2,3,4-tetrahydroisoquinoline-7-carboxamide | Discoidin Domain Receptor (DDR) | Tyrosine Kinase/Adaptors |
MitoBloCK-6 是一种有效的 Erv1/ALR 抑制剂,IC50 分别为 900 nM 和 700 nM。MitoBloCK-6 还抑制 Erv2 (IC50=1.4 μM)。MitoBloCK-6 可通过细胞色素 c 的释放诱导 hESCs 细胞凋亡。 | |||
T9658 | 2-Pyridinecarboxamide, 4-[[6-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]iminomethyl]amino]-3-pyridinyl]oxy]-N-methyl- | ||
TPL0388L | 1-[4-(1H-Imidazol-1-yl)phenyl]methanamine dihydrochloride | ||
TN7178 |
3-Amino-5-Hydroxybenzoic Acid
3-氨基-5-羟基苯甲酸; 3-amino-5-hydroxy-benzoic acid; 3-Amino-5-hydroxybenzoicAcid |
Others | Others |
3-Amino-5-Hydroxybenzoic Acid是一种海洋来源的天然产物,存在于Salinispora arenicola。 | |||
T9835 | 4-QUinolinecarboxamide, N-[3-[[[2-[4-(aminosulfonyl)phenyl]ethyl]amino]carbonyl]phenyl]-1,2-dihydro-2-oxo- | Others | Others |
4-QUinolinecarboxamide, N-[3-[[[2-[4-(aminosulfonyl)phenyl]ethyl]amino]carbonyl]phenyl]-1,2-dihydro-2-oxo-是胺。 | |||
T60193 | 1H-Indole-4-carboxamide, 2-methyl-1-[5,6,7,8-tetrahydro-4-[(phenylmethyl)amino]pyrido[2,3-d]pyrimidin-2-yl]- | p97 | Ubiquitination |
p97-IN-1 是有效的p97抑制剂,IC50<30 nM。 | |||
T9315 | 2H-Imidazo[4,5-b]pyrazin-2-one, 1,3-dihydro-6-[6-(1-hydroxy-1-methylethyl)-3-pyridinyl]-1-[(tetrahydro-2H-pyran-4-yl)methyl]- | Others | Others |
2H-Imidazo[4,5-b]pyrazin-2-one, 1,3-dihydro-6-[6-(1-hydroxy-1-methylethyl)-3-pyridinyl]-1-[(tetrahydro-2H-pyran-4-yl)methyl]- 是有效的mTOR抑制剂,对于mTOR和PI3Kα的IC50分别为0.176 μM 和 >30 μM。 | |||
T9970 |
1-ethyl-3-morpholin-4-yl-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile
1-ethyl-3-(morpholin-4-yl)-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile; 1-乙基-3-(1,4-氧杂氮杂环己-4-基)-5,6,7,8-四氢异喹啉-4-甲腈 |
GluR | Neuroscience |
1-ethyl-3-morpholin-4-yl-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile 是 mGluR3 的正变构调节剂,可用于治疗帕金森病的研究。 | |||
T9832 |
(Rac)-EC5026
Urea, N-[3-fluoro-4-(trifluoromethoxy)phenyl]-N'-[1-(2-methyl-1-oxobutyl)-4-piperidinyl]- |
Epoxide Hydrolase | Metabolism |
(Rac)-EC5026 ((Rac)-BPN-19186) 是一种有效的可溶性环氧水解酶 (sEH) 哌啶抑制剂,Ki值为 0.06 nM。(Rac)-EC5026 可用于帕金森氏病和路易体痴呆 (DLB) 的研究。 | |||
T60002 |
Ethyl 2-amino-4-methyl-5-[(3-nitrophenyl)carbamoyl]thiophene-3-carboxylate
DC-S239 |
Histone Methyltransferase | Chromatin/Epigenetic |
Ethyl 2-amino-4-methyl-5-[(3-nitrophenyl)carbamoyl]thiophene-3-carboxylate 是一种选择性的组蛋白甲基转移酶 SETD7 抑制剂 (IC50 = 4.59 μM),具有抗癌活性。 | |||
T20482L | Acth (1-4) acetate(19405-50-6 free base) | Others | Others |
Acth (1-4) acetate(19405-50-6 free base) 是 ACTH N 端四肽。 | |||
T9063 | N-[5-[(4-Bromophenyl)methylene]-4,5-dihydro-4-oxo-2-thiazolyl]-1-naphthalenesulfonamide | HIV Protease | Microbiology/Virology; Proteases/Proteasome |
Pitstop 2 是一种网格蛋白抑制剂,可通过与网格蛋白的末端域相关联来抑制网格蛋白介导的内吞作用,有潜力用于抗癌的研究。 | |||
T60126 | 4-(2-chloro-4-methoxy-5-methylphenyl)-N-[(1A)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-N-(2-propyn-1-yl)-2-thiazolamine | Others; CRFR | Others |
4-(2-chloro-4-methoxy-5-methylphenyl)-N-[(1A)-2-cyclopropyl-1-(3-fluoro-4-methylphenyl)ethyl]-5-methyl-N-(2-propyn-1-yl)-2-thiazolamine是SSR-125543的对映异构体. SSR-125543是一种有效的CRF-R1拮抗剂,对人CRF-R1的Ki=1.0nM。 | |||
T9229 | Pim-1/2 kinase inhibitor 1 | Pim | Chromatin/Epigenetic; JAK/STAT signaling |
Pim-1/2 kinase inhibitor 1 是一种具有口服活性的 Pim-1/2 激酶抑制剂。Pim-1/2 kinase inhibitor 1 能阻断Pim激酶磷酸化肽的能力,并且抑制4E-BP1和p27Kip1的Pim蛋白激酶定向磷酸化。Pim-1/2 kinase inhibitor 1 可用于癌症,尤其是前列腺癌的研究。 | |||
T7663L | Angiotensin 1/2 (1-9) TFA(34273-12-6(free base)) | Others | Others |
Angiotensin 1/2 (1-9)TFA is containing the amino acids 1-9 that are converted from Angiotensin I/II peptide. | |||
T29522L | N-[(1S)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]-N'-1H-indazol-4-ylurea | TRP/TRPV Channel | Membrane transporter/Ion channel |
N-[(1S)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]-N'-1H-indazol-4-ylurea 是一种有效的TRPV1拮抗剂,其IC50为123 nM,可阻断capsaicin对TRPV1的激活。 | |||
T9837 | N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-bromoaniline | ALK | Angiogenesis; Tyrosine Kinase/Adaptors |
N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-bromoaniline 是一种有效的 ALK5 抑制剂,IC50 为 7nM。 | |||
T9887 | Ethyl 1-[(4-cyanobenzyl)oxy]-2-(3-cyanophenyl)-4-methyl-1H-imidazole-5-carboxylate | Platelet aggregation | Others |
ethyl 1-[(4-cyanobenzyl)oxy]-2-(3-cyanophenyl)-4-methyl-1H-imidazole-5-carboxylate 是一种血小板聚集抑制剂。 | |||
T9256 | N-Cyclohexyl-4-[1-(1-piperazinyl)-2,6-naphthyridin-3-yl]-2-pyridinamine | Serine/threonin kinase; PKC | Cell Cycle/Checkpoint; Chromatin/Epigenetic; Cytoskeletal Signaling; Metabolism |
N-Cyclohexyl-4-[1-(1-piperazinyl)-2,6-naphthyridin-3-yl]-2-pyridinamine 是一种新型 2,6-naphthyridine,通过高通量筛选 (HTS) 鉴定为双蛋白激酶C/D (PKC/PKD) 抑制剂。 | |||
T60056 | Benzonitrile, 4-[[5-cyclopropyl-3-methyl-1-[(methylsulfonyl)methyl]-1H-pyrazol-4-yl]oxy]-2,6-dimethyl- | Progesterone Receptor | Others |
Benzonitrile, 4-[[5-cyclopropyl-3-methyl-1-[(methylsulfonyl)methyl]-1H-pyrazol-4-yl]oxy]-2,6-dimethyl- 是一种具有抗孕激素作用的孕酮受体拮抗剂。 | |||
T60124 | 1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(7-(1-methyl-1H-pyrazol-4-yl)-2,3,4,9-tetrahydro-1H-carbazol-3-yl)urea | TNF | Apoptosis |
1-(4-chloro-3-(trifluoromethyl)phenyl)-3-(7-(1-methyl-1H-pyrazol-4-yl)-2,3,4,9-tetrahydro-1H-carbazol-3-yl)urea是一种能够激动TNF-α的化合物,可以诱导细胞分泌TNF-α。 | |||
T60041 | N-[2-(5-Chloro-1H-indol-3-yl)ethyl]-4'-cyanobiphenyl-2-carboxaMide | Microtubule Associated | Cytoskeletal Signaling |
N-[2-(5-Chloro-1H-indol-3-yl)ethyl]-4'-cyanobiphenyl-2-carboxaMide是一种TAU细胞毒性抑制剂,抑制M17-TAU P301L细胞的LDH泄漏,EC50=325nM。 | |||
TN7125 | 2-Propen-1-one, 1-(2,6-dimethoxyphenyl)-3-(4-hydroxyphenyl)- | Others | Others |
2-Propen-1-one, 1-(2,6-dimethoxyphenyl)-3-(4-hydroxyphenyl)- 可用于对 L-苯丙氨酸解氨酶的抑制作用的研究。 | |||
TN7153 |
1-(2-hydroxyethyl)thymine
2,4(1H,3H)-Pyrimidinedione, 1-(2-hydroxyethyl)-5-methyl-; 1-(hydroxyethyl)thymine |
Others | Others |
1-(2-hydroxyethyl)thymine 是一种海洋来源的天然产物,存在于Zoanthus sp。 | |||
T9999 |
Benzamide, N-(3-imidazo[2,1-b]thiazol-6-ylphenyl)-2-methoxy
N-(3-(imidazo[2,1-b]thiazol-6-yl)phenyl)-2-methoxybenzamide |
Sirtuin; Others | Chromatin/Epigenetic; DNA Damage/DNA Repair; Others |
Benzamide, N-(3-imidazo[2,1-b]thiazol-6-ylphenyl)-2-methoxy 具有抗糖尿病、抗炎和抗肿瘤活性。 | |||
T7460 |
α-Cyano-4-hydroxycinnamic acid
2-氰基-4-羟基; α-Cyano-4-hydroxycinnamic acid(α-CHCA) |
Monocarboxylate transporter | Membrane transporter/Ion channel |
α-Cyano-4-hydroxycinnamic acid 是非竞争性单羧酸盐转运蛋白 (MCTs) 抑制剂,可抑制线粒体丙酮酸转运蛋白,Ki值为 6.3 μM。它可作为基质辅助激光解吸电离-飞行时间质谱 (MALDI-TOF) 分析的基质,可以促进肽离子化。 | |||
T9858 | 5-(3-bromo-4,5-dihydroisoxazol-5-yl)-3-(4-(tert-butyl)phenyl)-1,2,4-oxadiazole | Parasite | Microbiology/Virology |
5-(3-bromo-4,5-dihydroisoxazol-5-yl)-3-(4-(tert-butyl)phenyl)-1,2,4-oxadiazole 是一种基于 3-Br-isoxazoline 的疟原虫抑制剂恶性疟原虫(D10 和 W2 菌株)和利什曼原虫属。 (L. infantum 和 L.tropica) 前鞭毛体,IC50 为 0.035、0.058、3.5 和 7.5 μM。 | |||
T60162 | 1H-Pyrazole-5-carboxamide, 4-(5-chloro-2-furanyl)-1,3-bis(2,4-difluorophenyl)-4,5-dihydro-5-methyl-N-[(4-methyl-2-morpholinyl)methyl] | Others | Others |
1H-Pyrazole-5-carboxamide, 4-(5-chloro-2-furanyl)-1,3-bis(2,4-difluorophenyl)-4,5-dihydro-5-methyl-N-[(4-methyl-2-morpholinyl)methyl]是一种抗纤维化的化合物。 | |||
T60020 |
5'-Fluoro-5'-deoxyadenosine
5'-Fluoro-5'-deoxy-adenosine |
Others | Others |
5'-Fluoro-5'-deoxyadenosine常用作研究放线菌卡特链霉菌的工具。 | |||
T21708L |
Angiotensin 1/2 + A (2 - 8) Acetate
Angiotensin 1/2 + A (2 - 8) Acetate (51833-76-2 Free base) |
Others | Others |
Angiotensin 1/2 + A (2 - 8) Acetate 是一种血管收缩剂。 | |||
TP1389 | Exendin-3/4 (64-86) | Others | Others |
Exendin-3/4 (64-86) 是来自专利 CN 106029087 A 的多肽。 | |||
T21660L |
B-Casomorphin (1-3) Acetate
b-Casomorphin (1-3) Acetate (72122-59-9 Free base) |
Opioid Receptor | Endocrinology/Hormones; GPCR/G Protein; Neuroscience |
b-Casomorphin (1-3) Acetate 是一种具有阿片样物质作用的三肽。 | |||
T15919 | m-PEG7-4-nitrophenyl carbonate | Others | Others |
m-PEG7-4-nitrophenyl carbonate 是一种属于 PEG 类的 PROTAC linker,可用于 PROTAC 分子的合成。 | |||
T9882 | RUVBL1/2 ATPase-IN-1 | Others | Others |
RUVBL1/2 ATPase-IN-1 是一种有效的 RUVBL1/2 ATPase 抑制剂,IC50 值分别为 6.0 和 7.7 μM。 RUVBL1/2 ATPase-IN-1 可用于癌症疾病的研究。 | |||
TN7139 |
(3E)-4-(1H-indol-3-yl)but-3-en-2-one
4-(1H-indol-3-yl)but-3-en-2-one; (E)-4-(1H-indol-3-yl)but-3-en-2-one |
Others | Others |
(3E)-4-(1H-indol-3-yl)but-3-en-2-one是一种海洋来源的天然产物,存在于Tedania (Tedania) ignis。 | |||
T0634 | 2-Acetyl-4-butyramidophenol | Others | Others |
2-Acetyl-4-butyramidophenol 为灰色结晶粉末。 | |||
TN7067 |
3',5-Di-O-methyl quercetin
3,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-5-methoxy-4H-chromen-4-one |
Others | Others |
3,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-5-methoxy-4H-chromen-4-one (3',5-O-dimethylquercetin) 是一种黄酮类天然产物。 | |||
T8227 |
5'-Methylthioadenosine
5-脱氧-5-甲硫腺苷; 5'-Deoxy-5'-(methylthio)adenosine; 5'-S-Methyl-5'-thioadenosine; Methylthioadenosine; 5'-(Methylthio)-5'-deoxyadenosine |
Endogenous Metabolite | Metabolism |
5'-Methylthioadenosine 是由 S-腺苷蛋氨酸在多胺合成过程中生成的核苷,通过抑制肿瘤细胞增殖、侵袭和诱导细胞凋亡来抑制肿瘤,同时控制肿瘤组织的炎症微环境。 | |||
TN6719 | Kaempferol-3-O-β-D-glucosyl(1-2)rhamnoside | Others | Others |
Kaempferol-3-O-β-D-glucosyl(1-2)rhamnoside 是一种从阿拉伯茉莉中分离出来的天然产物。 | |||
T23535L |
Xanthine amine congener trihydrochloride
Xanthine amine congener trihydrochloride (96865-92-8 Free base) |
Adenosine Receptor | GPCR/G Protein; Neuroscience |
Xanthine amine congener trihydrochloride 是一种有效的腺苷拮抗剂,可逆转由腺苷激动剂 N6-环己基腺苷产生的尿流量、钠排泄和心率的减少。 | |||
T9752 | 3-(7,7-dimethyl-5-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-2-yl)-1H-indole-7-carbonitrile | Androgen Receptor | Endocrinology/Hormones |
3-(7,7-dimethyl-5-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-2-yl)-1H-indole-7-carbonitrile 是一种雄激素受体调节剂。 | |||
T9733 |
PAL-4
1H-1,2,4-Triazol-5-amine, 3-[[(4-chlorophenyl)methyl]thio]-1-[(2,3-dihydro-5-benzofuranyl)sulfonyl]- |
Others | Others |
PAL-4刺激 LYPLAL1 的活性, 一种特征不佳的丝氨酸水解酶,与人类代谢特征具有复杂的遗传联系。 | |||
T8502 | N-(1-benzyl-4-piperidyl)adamantane-1-carboxamide | Influenza Virus | Microbiology/Virology |
N-(1-benzyl-4-piperidyl)adamantane-1-carboxamide 通过与表面糖蛋白结合抑制埃博拉病毒进入宿主细胞,该化合物抑制埃博拉病毒,EC50 为 3.9 μM。 | |||
T60054 | EJMC-1 | TNF | Apoptosis |
EJMC-1 是一种 TNF-α 抑制剂,IC50 值为 42 μM,可用于自身炎症性疾病的研究。 | |||
TN7074 | (2E)-3-(1,3-Benzodioxol-5-yl)-2-propenoic acid | Antibiotic | Microbiology/Virology |
(2E)-3-(1,3-Benzodioxol-5-yl)-2-propenoic acid 对克氏锥虫的 EC50 值为 73.5 μM。 | |||
T9876 | Piperazine, 1-(4-fluorophenyl)-4-[(3,4,5-trimethoxyphenyl)methyl]- | Others | Others |
Piperazine,1-(4-fluorophenyl)-4-[(3,4,5-trimethoxyphenyl)methyl]-是一种哌嗪衍生物,显示出抗SARS-CoV-2活性。 | |||
T31532 |
Disperse Red 1
Diacelliton Scarlet B; Fenacet Scarlet B; Neosetile Scarlet B; Celliton Red B; Celliton Scarlet B; 分散红 1 |
Others | Others |
Disperse Red 1 是偶氮苯衍生物,是偶氮纺织品染料,普遍用于纺织工业中的聚酯织物染色。 | |||
TN7073 | 3-Feruloyl-4-caffeoylquinic acid | Others | Others |
3-Feruloyl-4-caffeoylquinic acid 是一种绿原酸异构体。绿原酸是相关的咖啡品质标志、味道和香气前体以及重要的生物活性化合物。 |